A Media Snippet accompanying this announcement is available in this link.

CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 /SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development of ...

Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...

25, 2025 — In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer.

Thanks to budget cuts, many potential insights and treatments needed to propel oncology forward will never be realized.

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

Erin Patterson is facing trial after pleading not guilty over a fatal mushroom lunch. Today, Nanette Rogers, SC, will present ...

The authors found that in 2023 there were 93 million CTs done on 62 million patients. The total estimated lifetime number of ...

Illuccix’s broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the VISION trial 6. The approval of Illuccix® in France has the potential to ...